Pfizer, Lilly and Bayer fined for price-fixing in Switzerland

he Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG were fined a total of $5.7 million by competition regulators on Dec. 1 for alleged price-fixing of drugs for erectile dysfunction.
Register for free to listen to this article
Listen with Speechify
0:00
1:00
BERN, Switzerland—The Swiss branches of Pfizer Inc., EliLilly & Co. and Bayer AG were fined a total of $5.7 million by competitionregulators on Dec. 1 for alleged price-fixing of drugs for erectiledysfunction. The Swiss Competition Commission contends that the prices forViagra (sildenafil), Cialis (tadalafil) and Levitra (vardenafil) were fixed viapublic price recommendations. The commission didn't say how much each companywas fined, and declined to provide the information. The commission concluded inFebruary, after a lengthy investigation that began in June 2006, that the firmsmade "inadmissible vertical competition agreements" by maintaining arecommended public selling price for the drugs. The three companies rejectedthe allegations.
  
 
  
 
  
  
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.
Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.
Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.
Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.
Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue